Foster Corp. Enters into Partnership with LioChem to Expand Medical Color Masterbatch Capability

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System,...

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners ("LLCP"), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC ("FlexXray" or...

Foster Corporation provides polymer solutions for medical device and pharmaceutical applications. Today the company announced a new partnership with LioChem, a global player in masterbatch and colorants in the plastics industry. LioChem’s expertise will serve to augment, and expand, Foster’s current capability in supply of medical color masterbatch by offering larger volume capability as well as providing expertise in critical color matching situations with excellent color match turn-around service levels.

LioChem’s Lioplax* MD color masterbatch products are custom formulated and manufactured exclusively for the critical medical device market using FDA approved 21 CFR 73 Subpart D pigments. Lioplax MD color masterbatch products are also available in a wide variety of base carrier medical-grade bio tested (USP Class VI/ISO 10993) polymers which can withstand a variety of sterilization techniques.

According to Marcela Linares, Foster’s Market Development Manager, “LioChem are experts in color and color masterbatch products. Because of this expertise they can provide knowledgeable technical support to potential customers looking for guidance regards their medical color needs. The company’s extensive experience with pigments, additives, and resins provides a unique opportunity to support design, prototyping, and production in large and small volumes for critical applications.”

Linares continues; “The medical market for color is growing at a brisk rate and, at the same time, medical color needs are getting more complex. With the addition of the LioChem partnership, we (Foster) will strengthen our capabilities and expand our offerings to satisfy the color compound needs of our customers; which will enable them to get to market faster with the confidence that their products will comply with the regulatory needs that the medical device industry requires.”

Applications for Lioplax MD masterbatch products include medical housings, surgical instruments, fluid management, dialysis, packaging, medical tubing, respiratory & anesthesiology, endoscopy, labware as well as many other medical application segments.



Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.